Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2024-05-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$133.4m
reported value
-6.4% vs Q4 2023
10positions
100.0%in top 10
1 new
2 added
5 reduced
0 sold out
vs Q4 2023
Holdings, Q1 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN ARWR | $26.0m19.47% | Unchanged |
| REGENXBIO INC RGNX | $19.1m14.31% | Added +103.8k |
| BLUEPRINT MEDICINES CORP BPMC | $17.3m12.95% | Reduced -72.7k |
| ARVINAS INC ARVN | $16.8m12.55% | Reduced -83.4k |
| KYMERA THERAPEUTICS INC KYMR | $15.6m11.71% | Reduced -492.6k |
| SILENCE THERAPEUTICS PLC SLN | $12.4m9.30% | Reduced -469.1k |
| MERUS N V MRUS | $11.5m8.61% | Reduced -100.0k |
| SUTRO BIOPHARMA INC COM | $6.6m4.94% | Added +744.8k |
| PRECISION BIOSCIENCES INC DTIL | $5.2m3.92% | New |
| REPARE THERAPEUTICS INC RPTX | $3.0m2.24% | Unchanged |